Breast Cancer Research (Aug 2021)
Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation
- Maximiliano Ribeiro Guerra,
- Juliette Coignard,
- Séverine Eon-Marchais,
- Marie-Gabrielle Dondon,
- Dorothée Le Gal,
- Juana Beauvallet,
- Noura Mebirouk,
- Muriel Belotti,
- Olivier Caron,
- Marion Gauthier-Villars,
- Isabelle Coupier,
- Bruno Buecher,
- Alain Lortholary,
- Jean-Pierre Fricker,
- Paul Gesta,
- Catherine Noguès,
- Laurence Faivre,
- Pascaline Berthet,
- Elisabeth Luporsi,
- Capucine Delnatte,
- Valérie Bonadona,
- Christine M. Maugard,
- Pascal Pujol,
- Christine Lasset,
- Michel Longy,
- Yves-Jean Bignon,
- Claude Adenis-Lavignasse,
- Laurence Venat-Bouvet,
- Hélène Dreyfus,
- Laurence Gladieff,
- Isabelle Mortemousque,
- Séverine Audebert-Bellanger,
- Florent Soubrier,
- Sophie Giraud,
- Sophie Lejeune-Dumoulin,
- Jean-Marc Limacher,
- Jean Chiesa,
- Anne Fajac,
- Anne Floquet,
- François Eisinger,
- Julie Tinat,
- Sandra Fert-Ferrer,
- Chrystelle Colas,
- Thierry Frebourg,
- Francesca Damiola,
- Laure Barjhoux,
- Eve Cavaciuti,
- Sylvie Mazoyer,
- Anne Tardivon,
- Fabienne Lesueur,
- Dominique Stoppa-Lyonnet,
- Nadine Andrieu
Affiliations
- Maximiliano Ribeiro Guerra
- INSERM, U900
- Juliette Coignard
- INSERM, U900
- Séverine Eon-Marchais
- INSERM, U900
- Marie-Gabrielle Dondon
- INSERM, U900
- Dorothée Le Gal
- INSERM, U900
- Juana Beauvallet
- INSERM, U900
- Noura Mebirouk
- INSERM, U900
- Muriel Belotti
- Institut Curie, Service de Génétique
- Olivier Caron
- Gustave Roussy, Département de Médecine Oncologique, Université Paris-Saclay
- Marion Gauthier-Villars
- Institut Curie, Service de Génétique
- Isabelle Coupier
- Hôpital Arnaud de Villeneuve, CHU Montpellier, Service de Génétique Médicale et Oncogénétique
- Bruno Buecher
- Institut Curie, Service de Génétique
- Alain Lortholary
- Centre Catherine de Sienne, Service d’Oncologie Médicale
- Jean-Pierre Fricker
- Centre Paul Strauss, Unité d’Oncologie
- Paul Gesta
- CH Georges Renon, Service d’Oncogénétique Régional Poitou-Charentes
- Catherine Noguès
- Département d’Anticipation et de Suivi des Cancers, Oncogénétique Clinique, Institut Paoli Calmettes
- Laurence Faivre
- Institut GIMI, CHU de Dijon, Hôpital d’Enfants
- Pascaline Berthet
- Centre François Baclesse, Unité de pathologie gynécologique
- Elisabeth Luporsi
- Service de Génétique UF4128 CHR Metz-Thionville, Hôpital de Mercy
- Capucine Delnatte
- Centre René Gauducheau, Unité d’Oncogénétique
- Valérie Bonadona
- Université Claude Bernard Lyon 1
- Christine M. Maugard
- Génétique Oncologique moléculaire, UF1422, Département d’Oncobiologie, LBBM, Hôpitaux Universitaires de Strasbourg
- Pascal Pujol
- Hôpital Arnaud de Villeneuve, CHU Montpellier, Service de Génétique Médicale et Oncogénétique
- Christine Lasset
- Université Claude Bernard Lyon 1
- Michel Longy
- Institut Bergonié
- Yves-Jean Bignon
- Département d’oncogénétique, Centre Jean Perrin, Université Clermont Auvergne, UMR INSERM 1240
- Claude Adenis-Lavignasse
- Polyclinique de la Louvière (groupe Ramsay)
- Laurence Venat-Bouvet
- Service d’Oncologie Médicale, Hôpital Universitaire Dupuytren
- Hélène Dreyfus
- Clinique Sainte Catherine
- Laurence Gladieff
- Institut Claudius Regaud – IUCT-Oncopole, Service d’Oncologie Médicale
- Isabelle Mortemousque
- Service de Génétique, Hôpital Bretonneau
- Séverine Audebert-Bellanger
- Département de Génétique Médicale et Biologie de la Reproduction, Hôpital Morvan, CHU Brest
- Florent Soubrier
- Hôpital Tenon
- Sophie Giraud
- Hospices Civils de Lyon, Service de Génétique, Groupement Hospitalier EST
- Sophie Lejeune-Dumoulin
- Clinique de Génétique Médicale Guy Fontaine, CHU Lille
- Jean-Marc Limacher
- Service d’Onco-hématologie, Hôpital Pasteur
- Jean Chiesa
- Service d’Oncologie Médicale, CHRU Hôpital Caremeau
- Anne Fajac
- Service d’Oncogénétique, Hôpital Tenon
- Anne Floquet
- Institut Bergonié
- François Eisinger
- Département d’Anticipation et de Suivi des Cancers, Oncogénétique Clinique, Institut Paoli Calmettes
- Julie Tinat
- Groupe Hospitalier Pellegrin, Service de génétique médicale, CHU De Bordeaux
- Sandra Fert-Ferrer
- Centre Hospitalier Métropole Savoie
- Chrystelle Colas
- Institut Curie, Service de Génétique
- Thierry Frebourg
- Département de Génétique, Hopital Universitaire de Rouen
- Francesca Damiola
- Department of Biopathology, Pathology Research platform, Centre Léon Bérard
- Laure Barjhoux
- GCS AURAGEN, Plateforme de Génétique, Hôpital Edouart Herriot
- Eve Cavaciuti
- INSERM, U900
- Sylvie Mazoyer
- Centre de Recherche en Neurosciences de Lyon, INSERM U1028, CNRS UMR5292, Université Lyon 1, Université Saint Etienne
- Anne Tardivon
- Service de Radiologie, Institut Curie
- Fabienne Lesueur
- INSERM, U900
- Dominique Stoppa-Lyonnet
- Institut Curie, Service de Génétique
- Nadine Andrieu
- INSERM, U900
- DOI
- https://doi.org/10.1186/s13058-021-01456-1
- Journal volume & issue
-
Vol. 23,
no. 1
pp. 1 – 18
Abstract
Abstract Background Diagnostic ionizing radiation is a risk factor for breast cancer (BC). BC risk increases with increased dose to the chest and decreases with increased age at exposure, with possible effect modification related to familial or genetic predisposition. While chest X-rays increase the BC risk of BRCA1/2 mutation carriers compared to non-carriers, little is known for women with a hereditary predisposition to BC but who tested negative for a BRCA1 or BRCA2 (BRCA1/2) mutation. Methods We evaluated the effect of chest X-rays from diagnostic medical procedures in a dataset composed of 1552 BC cases identified through French family cancer clinics and 1363 unrelated controls. Participants reported their history of X-ray exposures in a detailed questionnaire and were tested for 113 DNA repair genes. Logistic regression and multinomial logistic regression models were used to assess the association with BC. Results Chest X-ray exposure doubled BC risk. A 3% increased BC risk per additional exposure was observed. Being 20 years old or younger at first exposure or being exposed before first full-term pregnancy did not seem to modify this risk. Birth after 1960 or carrying a rare likely deleterious coding variant in a DNA repair gene other than BRCA1/2 modified the effect of chest X-ray exposure. Conclusion Ever/never chest X-ray exposure increases BC risk 2-fold regardless of age at first exposure and, by up to 5-fold when carrying 3 or more rare variants in a DNA repair gene. Further studies are needed to evaluate other DNA repair genes or variants to identify those which could modify radiation sensitivity. Identification of subpopulations that are more or less susceptible to ionizing radiation is important and potentially clinically relevant.
Keywords